Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Department of Population Health, NYU Grossman School of Medicine, New York, NY, USA.
Public Health. 2023 Jan;214:163-170. doi: 10.1016/j.puhe.2022.10.021. Epub 2022 Dec 29.
The aims of the study were to describe the up-to-date trend of total, diagnosed, and undiagnosed diabetes and prediabetes, assess their associated disparities among population subgroups, and examine their relationship with sociodemographic factors among adults in the United States.
This was a cross-sectional study from a nationally representative sample of US adults (aged ≥20 years) who participated in the National Health and Nutrition Examination Survey.
Diagnosed diabetes was defined as a self-reported previous diagnosis of diabetes by a physician or any other health professionals (other than during pregnancy). Undiagnosed diabetes was defined as elevated levels of fasting plasma glucose (≥126 mg/dL) or HbA (≥6.5%). Total diabetes included those who had either diagnosed or undiagnosed diabetes. Prediabetes was defined as an HbA level of 5.7%-6.4% or a fasting plasma glucose level of 100-125 mg/dL. All estimates were age standardized to the 2010 US census population for age groups 20-44, 45-64, and 65+ years. All analyses accounted for the complex survey design. Logistic regressions were used to conduct the analyses.
A total of 21,600 (mean, 47.2 years [SD, 14.7]) individuals were analyzed. From 1999 to 2018, the age-standardized prevalence increased significantly from 9.17% to 14.7% (difference, 5.52%; 95% confidence interval [CI], 2.69%-8.35%; P-trend <0.001) for total diabetes, increased from 6.15% to 11.0% (difference, 4.79%; 95% CI, 2.27%-7.32%; P-trend<0.001) for diagnosed diabetes and remained stable from 3.01% to 3.73% (difference, 0.72%; 95% CI, -0.47% to 1.91%; P-trend = 0.19) for undiagnosed diabetes. The age-standardized prevalence of prediabetes increased significantly from 29.5% to 48.3% (difference, 18.8%; 95% CI, 13.3%-24.4%; P-trend<0.001). Disparities persisted with higher prevalence among adults with obesity and populations that have been marginalized, including racial and ethnic minorities, low income, less educated Americans, and those living in food-insecure household.
The prevalence of diabetes and prediabetes increased significantly from 1999 to 2018 among US adults. There are substantial and persistent disparities among racial and ethnic minorities, populations experiencing socio-economic disadvantages, and adults with obesity.
本研究旨在描述美国成年人中糖尿病、确诊糖尿病和未确诊糖尿病以及糖尿病前期的最新流行趋势,评估不同人群亚组之间的差异,并研究这些疾病与社会人口因素之间的关系。
这是一项基于美国成年人(年龄≥20 岁)的全国代表性样本的横断面研究,参与者参加了国家健康和营养检查调查。
确诊糖尿病定义为医生或任何其他健康专业人员(非妊娠期间)报告的既往糖尿病诊断。未确诊糖尿病定义为空腹血糖水平升高(≥126mg/dL)或糖化血红蛋白(HbA)水平升高(≥6.5%)。总糖尿病包括已确诊或未确诊的糖尿病患者。糖尿病前期定义为 HbA 水平为 5.7%-6.4%或空腹血糖水平为 100-125mg/dL。所有估计值均按年龄标准化,以 2010 年美国人口普查人口为基准,年龄组为 20-44 岁、45-64 岁和 65 岁以上。所有分析均考虑了复杂的调查设计。使用逻辑回归进行分析。
共分析了 21600 名(平均年龄 47.2 岁[SD,14.7])个体。从 1999 年到 2018 年,年龄标准化患病率从 9.17%显著上升至 14.7%(差异 5.52%;95%置信区间[CI],2.69%-8.35%;P 趋势<0.001),总糖尿病患病率上升,从 6.15%上升至 11.0%(差异 4.79%;95%CI,2.27%-7.32%;P 趋势<0.001),而未确诊糖尿病的患病率从 3.01%稳定至 3.73%(差异 0.72%;95%CI,-0.47%至 1.91%;P 趋势=0.19)。糖尿病前期的年龄标准化患病率从 29.5%显著上升至 48.3%(差异 18.8%;95%CI,13.3%-24.4%;P 趋势<0.001)。肥胖和边缘化人群(包括种族和民族少数群体、低收入、受教育程度较低的美国人以及生活在粮食不安全家庭中的人群)中,这些疾病的患病率仍然存在显著差异。
1999 年至 2018 年期间,美国成年人中糖尿病和糖尿病前期的患病率显著上升。在种族和民族少数群体、经历社会经济劣势的人群以及肥胖成年人中,仍然存在大量且持续的差异。